BlueCrest Capital Management’s Biote Corp. Warrant BTMDW Stock Holding History

BlueCrest Capital Management’s Portfolio BTMDW Stock Details BTMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-25,474,500	Closed	-$76.4K	–	300
2022 Q4	$76.4K	Buy	25,474,500 +25,219,755	+9,900%	+$6.87M	﹤0.01%	140
2022 Q3	$87K	Hold	254,745	–	–	﹤0.01%	159
2022 Q2	$109K	Buy	254,745 +600	+0.2%	+$324	﹤0.01%	166
2022 Q1	$140K	Buy	+254,145	New	+$121K	﹤0.01%	250

Other funds holding BTMDW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

SRF

Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

BlueCrest Capital Management's BTMDW Position: Q1 2023 in Review

BlueCrest Capital Management sold out of Biote Corp. Warrant (BTMDW) in Q1 2023, closing a stake of 25,474,500 shares — an estimated $76.4K sold.

BlueCrest Capital Management first reported a position in BTMDW in Q1 2022 and held it in 4 quarters. The position peaked at $140K in Q1 2022. 34 funds tracked by Wall St. Rank hold BTMDW as of Q1 2023.

BlueCrest Capital Management reported no remaining Biote Corp. Warrant position as of Q1 2023 after selling out during the quarter.
BlueCrest Capital Management sold 25,474,500 Biote Corp. Warrant shares in Q1 2023, an estimated $76.4K.
BlueCrest Capital Management first reported a position in Biote Corp. Warrant in Q1 2022 and held it in 4 quarters.
BlueCrest Capital Management's Biote Corp. Warrant position peaked at $140K in Q1 2022.
34 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q1 2023.

Based on BlueCrest Capital Management's 13F filing for Q1 2023, filed 15 May 2023.